<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28392573</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2042-0226</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cellular &amp; molecular immunology</Title><ISOAbbreviation>Cell Mol Immunol</ISOAbbreviation></Journal><ArticleTitle>Inducible Rubicon facilitates viral replication by antagonizing interferon production.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>620</EndPage><MedlinePgn>607-620</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/cmi.2017.1</ELocationID><Abstract><AbstractText>The RUN domain Beclin-1-interacting cysteine-rich-containing (Rubicon) protein is involved in the maturation step of autophagy and the endocytic pathway as a Beclin-1-binding partner, but little is known regarding the role of Rubicon during viral infection. Here, we performed functional studies of the identified target in interferon (IFN) signaling pathways associated with Rubicon to elucidate the mechanisms of viral resistance to IFN. The Rubicon protein levels were elevated in peripheral blood mononuclear cells, sera and liver tissues from patients with hepatitis B virus (HBV) infection relative to those in healthy individuals. Assays of the overexpression and knockdown of Rubicon showed that Rubicon significantly promoted HBV replication. In addition, Rubicon knockdown resulted in the inhibition of enterovirus 71, influenza A virus and vesicular stomatitis virus. The expression o0f Rubicon led to the suppression of virus-induced type-I interferon (IFN-&#x3b1; and IFN-&#x3b2;) and type-III interferon (IFN-&#x3bb;1). Translocation of activated IRF3 and IRF7 from the cytoplasm to the nucleus was involved in this process, and the NF-&#x3ba;B essential modulator (NEMO), a key factor in the IFN pathway, was the target with which Rubicon interacted. Our results reveal a previously unrecognized function of Rubicon as a virus-induced protein that binds to NEMO, leading to the inhibition of type-I interferon production. Rubicon thus functions as an important negative regulator of the innate immune response, enhances viral replication and may play a role in viral immune evasion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Yushun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>TieLong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broering</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Faculty, Department of Gastroenterology and Hepatology, University of Duisburg-Essen, Essen 45127, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mengji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Virology, University of Duisburg-Essen, Essen 45127, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cell Mol Immunol</MedlineTA><NlmUniqueID>101242872</NlmUniqueID><ISSNLinking>1672-7681</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491731">IKBKG protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C552537">RUBCN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.10</RegistryNumber><NameOfSubstance UI="D051550">I-kappa B Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell Mol Immunol. 2019 Sep;16(9):770-771. doi: 10.1038/s41423-019-0248-7</RefSource><PMID Version="1">31164715</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019694" MajorTopicYN="N">Hepatitis B, Chronic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051550" MajorTopicYN="N">I-kappa B Kinase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28392573</ArticleId><ArticleId IdType="pmc">PMC5520414</ArticleId><ArticleId IdType="doi">10.1038/cmi.2017.1</ArticleId><ArticleId IdType="pii">cmi20171</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vilcek J. Fifty years of interferon research: aiming at a moving target. Immunity 2006; 25: 343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">16979566</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202: 8&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15546383</ArticleId></ArticleIdList></Reference><Reference><Citation>Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6: 975&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097588</ArticleId><ArticleId IdType="pubmed">18049472</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen MH, Paludan SR. Viral evasion of DNA-stimulated innate immune responses. Cell Mol Immunol 2016; 14: 4&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5214947</ArticleId><ArticleId IdType="pubmed">26972769</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Q, Xie J, Kim HJ, Ma X. Type I interferon: the mediator of bacterial infection-induced necroptosis. Cell Mol Immunol 2013; 10: 4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003178</ArticleId><ArticleId IdType="pubmed">23085950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395: 297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">9751060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93: 1231&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">9657155</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K, Nanda S, Cohen P. Molecular control of the NEMO family of ubiquitin-binding proteins. Nat Rev Mol Cell Biol 2013; 14: 673&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989959</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark K, Takeuchi O, Akira S, Cohen P. The TRAF-associated protein TANK facilitates cross-talk within the I kappa B kinase family during Toll-like receptor signaling. Proc Natl Acad Sci USA 2011; 108: 17093&#x2013;17098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3193242</ArticleId><ArticleId IdType="pubmed">21949249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300: 1148&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">12702806</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 2007; 8: 592&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">17468758</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsunaga K, Noda T, Yoshimori T. Binding Rubicon to cross the Rubicon. Autophagy 2009; 5: 876&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pubmed">19550146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y, Wang QJ, Li XT, Yan Y, Backer JM, Chait BT et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 2009; 11: 468&#x2013;U262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664389</ArticleId><ArticleId IdType="pubmed">19270693</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CS, Rodgers M, Min CK, Lee JS, Kingeter L, Lee JY et al. The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity. Cell Host Microbe 2012; 11: 277&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615900</ArticleId><ArticleId IdType="pubmed">22423967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S et al. The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus. Immunity 2015; 42: 123&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">25557055</ArticleId></ArticleIdList></Reference><Reference><Citation>Luangsay S, Gruffaz M, Isorce N, Testoni B, Michelet M, Faure-Dupuy S et al. Early inhibition of hepatocyte innate responses by hepatitis B virus. J Hepatol 2015; 63: 1314&#x2013;1322.</Citation><ArticleIdList><ArticleId IdType="pubmed">26216533</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Peng N, Xie J, Hao Q, Zhang M, Zhang Y et al. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways. J Hepatol 2015; 62: 1015&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pubmed">25481566</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HJ, Dinarello CA, Shapiro L. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J Infect Dis 2001; 184: 560&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pubmed">11494162</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner M, Driftmann S, Kleinehr K, Kaiser GM, Mathe Z, Treckmann JW et al. All-in-one: advanced preparation of human parenchymal and non-parenchymal liver cells. PLoS ONE 2015; 10: e0138655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4583235</ArticleId><ArticleId IdType="pubmed">26407160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X, Wang H, Zhao F, Liu S, Wu J, Ren W et al. Hepatitis B virus-induced calreticulin protein is involved in IFN resistance. J Immunol 2012; 189: 279&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">22661095</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xie J, Xu X, Liu L, Wan Y, Liu Y et al. Inducible interleukin 32. IL-32) exerts extensive antiviral function via selective stimulation of interferon lambda1. IFN-lambda1. J Biol Chem 2013; 288: 20927&#x2013;20941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774363</ArticleId><ArticleId IdType="pubmed">23729669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Cui L, Wang Y, Yang GF, He J, Hao RD et al. Hepatitis B e Antigen and Its Precursors Promote the Progress of Hepatocellular Carcinoma by Interacting With NUMB and Decreasing p53 Activity. Hepatology 2016; 64: 390&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">27106262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun QM, Zhang J, Fan WL, Wong KN, Ding XJ, Chen S et al. The RUN domain of rubicon is important for hVps34 binding, lipid kinase inhibition, and autophagy suppression. J Biol Chem 2011; 286: 185&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012973</ArticleId><ArticleId IdType="pubmed">21062745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu ZB, Fotouhi-Ardakani N, Wu LT, Maoui M, Wang SL, Banville D et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem 2002; 277: 40247&#x2013;40252.</Citation><ArticleIdList><ArticleId IdType="pubmed">12177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T, Wan Y, Wang J, Zhao P, Yuan Y, Wang L et al. Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway. Journal of immunology 2015; 194: 2757&#x2013;2768.</Citation><ArticleIdList><ArticleId IdType="pubmed">25681344</ArticleId></ArticleIdList></Reference><Reference><Citation>Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T et al. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 2012; 122: 529&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3266786</ArticleId><ArticleId IdType="pubmed">22251702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu HB, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996; 93: 13973&#x2013;13978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19479</ArticleId><ArticleId IdType="pubmed">8943045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Tian Y, Ou JH. HCV induces the expression of Rubicon and UVRAG to temporally regulate the maturation of autophagosomes and viral replication. PLoS Pathog 2015; 11: e1004764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4373777</ArticleId><ArticleId IdType="pubmed">25807108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol 2016; 64: S4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4834849</ArticleId><ArticleId IdType="pubmed">27084035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F, Xu G, Zhou Y, Wang L, Xie J, Ren S et al. MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein. J Biol Chem 2014; 289: 35029&#x2013;35041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263898</ArticleId><ArticleId IdType="pubmed">25342750</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng M, Xin X, Bi LQ, Zhou LT, Liu XH. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World J Gastroenterol 2015; 21: 10732&#x2013;10738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4600575</ArticleId><ArticleId IdType="pubmed">26478665</ArticleId></ArticleIdList></Reference><Reference><Citation>Decorsiere A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK et al. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature 2016; 531: 386&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">26983541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hao Q, Peng NF, Yue X, Wang Y, Chen YN et al. Major vault protein: A virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology 2012; 56: 57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MJ, Dennin R, Kramer C, Jones G, Connell E, Rolon N et al. Cell and virus sensitivity studies with recombinant human alpha interferons. J Interferon Res 1983; 3: 425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">6323591</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Zhao X, Sun D, Yang L, Chong C, Pan Y et al. Interferon alpha. IFNalpha)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. Cell Mol Immunol 2016; 13: 94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4711679</ArticleId><ArticleId IdType="pubmed">25683609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MT, Chen SS. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection. Cell Mol Immunol 2016; 13: 11&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712384</ArticleId><ArticleId IdType="pubmed">25544499</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LM, Jung JU. Modulation of the autophagy pathway by human tumor viruses. Semin Cancer Biol 2013; 23: 323&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791178</ArticleId><ArticleId IdType="pubmed">23727156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Sir D, Kuo CF, Ann DK, Ou JH. Autophagy required for hepatitis B virus replication in transgenic mice. Journal of virology 2011; 85: 13453&#x2013;13456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233133</ArticleId><ArticleId IdType="pubmed">21957292</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu Y, Wang Z, Liu K, Wang Y, Liu J et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. Journal of virology 2011; 85: 6319&#x2013;6333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126540</ArticleId><ArticleId IdType="pubmed">21507968</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CS, Lee JS, Rodgers M, Min CK, Lee JY, Kim HJ et al. Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe 2012; 11: 264&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616771</ArticleId><ArticleId IdType="pubmed">22423966</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wang Q, Han T, Li YK, Zhu SL, Ao F et al. Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst. Cell Mol Immunol 2015; 12: 633&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579649</ArticleId><ArticleId IdType="pubmed">25176527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S, Wang J, Chen TL, Li HY, Wan YS, Peng NF et al. Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms. PLoS One 2016; 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4811540</ArticleId><ArticleId IdType="pubmed">27023403</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 1997; 17: 503&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">9335428</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA et al. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 2005; 192: 1741&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pubmed">16235172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonjardim CA, Ferreira PC, Kroon EG. Interferons: signaling, antiviral and viral evasion. Immunol Lett 2009; 122: 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112942</ArticleId><ArticleId IdType="pubmed">19059436</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Takaoka A, Taniguchi T. Type I inteferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006; 25: 349&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">16979567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R, Mamane Y, Hiscott J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 1999; 19: 2465&#x2013;2474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84039</ArticleId><ArticleId IdType="pubmed">10082512</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver BK, Kumar KP, Reich NC. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 1998; 18: 1359&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC108849</ArticleId><ArticleId IdType="pubmed">9488451</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappa B activation. Cell 2009; 136: 1098&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19303852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo YC, Lin SC, Rospigliosi CC, Conze DB, Wu CJ, Ashwell JD et al. Structural basis for recognition of diubiquitins by NEMO. Mol Cell 2009; 33: 602&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749619</ArticleId><ArticleId IdType="pubmed">19185524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>